Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors
Clinical trial NCT00703638 · COMPLETED
Trial details
- NCT number
- NCT00703638
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2010-09-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.